IP Library Granted Patent US 8,236,862
Granted Patent B2
US 8,236,862 · App. 12/700,614 · Granted Aug 7, 2012

Therapeutic compositions comprising monoterpenes

Assignee: University of Southern California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,236,862
App. No.
12/700,614
Granted
Aug 7, 2012
Kind
B2
Abstract

This invention provides a compositions for transport of a therapeutic agent. The compositions contain a therapeutic agent and a monoterpene or an analog thereof. In one aspect, the monoterpene is perillyl alcohol (POH) or an analog thereof. In one aspect, the therapeutic agent is provided in an amount effective to treat the disease or subject of choice.

Claims (20)

1. A composition for administration by one or more of inhalation, intranasally or ocularly, comprising:

a therapeutic agent;

from about 0.0001% to about 0.01% (v/v) of perillyl alcohol, perillaldehyde or a carboxylic acid ester of perillyl alcohol;

at least about 1.3% glycerol (v/v); and

at least about 1.3% ethanol, (v/v),

wherein the components equal 100% (v/v) of the composition.

2. A composition for administration by one or more of inhalation, intranasally or ocularly, consisting essentially of:

a therapeutic agent;

from about 0.0001% to about 0.01% (v/v) of perillyl alcohol, perillaldehyde or a carboxylic acid ester of perillyl alcohol;

at least about 1.3% glycerol (v/v); and

at least about 1.3% ethanol, (v/v),

wherein the components equal 100% (v/v) of the composition.

3. The composition of claim 1 , wherein the composition comprises perillyl alcohol.

4. The composition of claim 1 or 2 , wherein the therapeutic agent is a chemotherapeutic agent or a therapeutic antibody.

5. The composition of claim 1 or 2 , wherein the therapeutic agent is temozolomide or dimethylcelecoxib.

6. The composition of claim 1 or 2 , formulated for pediatric administration.

7. The composition of claim 1 or 2 , wherein the therapeutic agent treats a neurological disorder or a cancer affecting the central nervous system.

8. A kit comprising the composition of claim 1 or 2 , a device for administering the composition by inhalation and instruction for use of the device.

9. The composition of claim 1 or 2 , wherein the perillyl alcohol, perillaldehyde or a carboxylic acid ester of perillyl alcohol is present in an amount from about 0.001% to about 0.01% (v/v).

10. The composition of claim 1 or 2 , wherein the perillyl alcohol, perillaldehyde or a carboxylic acid ester of perillyl alcohol is present in an amount of about 0.01% (v/v).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2010
From: CHEN, THOMAS C.; DA FONSECA, CLOVIS O.; DOS SANTOS, THEREZA QUIRICO; SCHWARTSMANN, GILBERTO
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 024429/0793 →
Continuity (2)
Provisional Application 61150714 · Feb 6, 2009
Related Publication 20100226913A1 · Sep 9, 2010